Chronic gastritis and Helicobacter pylori

Seminars in Gastrointestinal Disease

Volumn 12, Issue 3, 2001, Pages 196-202

  Cave, D R ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CASE REPORT; CHRONIC GASTRITIS; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; DUODENUM ULCER; EPIGASTRIC PAIN; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HOST PARASITE INTERACTION; HUMAN; INTESTINE METAPLASIA; MALE; PHYSIOLOGY; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CARCINOMA; STOMACH PROTECTION; SYMPTOM;

BARRETT ESOPHAGUS; DUODENAL ULCER; GASTRIC ACID; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROTON PUMPS; STOMACH NEOPLASMS; STOMACH ULCER;

EID: 0034937908     PISSN: 10495118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Cancer statistics, 97
2. Type A and B atrophic gastritis
3. Classification and grading of gastritis
4. Attempt to fulfil Koch's postulates for pyloric campylobacter
5. Helicobacter pylori infection and the risk of gastric carcinoma
6. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii
7. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation
8. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: A prospective, randomized study
9. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting pH
10. Epidemic gastritis with hypochlorhydria
11. Effect of a campylobacter pylori protein on acid secretion by parietal cells
12. Interleukin-8 expression in Helicobacter pylori infected and neoplastic gastroduodenal mucosa
13. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease
14. The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomach
15. Helicobacter pylori infection and the pathogenesis of duodenal ulceration
16. Gastric acid secretory response in Helicobacter pylori-positive patients with duodenal ulcer disease
17. Effects of Helicobacter pylori gastritis on gastric secretion in healthy human beings
18. Helicobacter pylori gastritis and seum pepsinogen A in a male non-patient population
19. Simple atrophic gastritis and gastric carcinoma
20. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus
21. Corpus gastritis is protective against reflux oesophagitis
22. Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H. pylori
23. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
24. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole
25. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer
26. Studies on the interrelation between Zollinger-Ellison syndrome, Helicobacter pylori, and proton pump inhibitor therapy
27. Human gastric carcinogenesis: A multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention
28. Chronic gastritis as a cancer precursor
29. Interobserver variability in application of the revised Sydney classification for gastritis
30. Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis
31. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication
32. Lack of effect of acid suppression therapy on gastric atrophy
33. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
34. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis
35. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: Impacts of hiatal hernia and corpus gastritis
36. Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux
37. Helicobacter pylori and gastroesophageal reflux disease: Lack of influence of infection on twenty-four-hour esophageal pH monitoring and endoscopic findings
38. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: Impact of gastroesophageal reflux disease
39. Effects of aging and gastritis on gastric acid and pepsin secretion in humans: A prospective study
40. The mature stomach. Still pumping out acid?
41. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated
42. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia
43. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: A prospective, randomized study
44. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer